TY - JOUR
T1 - Dysostosis Multiplex in Human Mucopolysaccharidosis Type 1 H and in Animal Models of the Disease
AU - Hampe, Christiane S.
AU - Polgreen, Lynda E.
AU - Lund, Troy C.
AU - McIvor, R. Scott
N1 - Publisher Copyright:
Copyright© of YS Medical Media ltd.
Copyright:
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder, caused by deficiency of α-L-iduronidase, and consequent accumulation of dermatan and heparan sulfates. Severity of the disease ranges from mild (Scheie) to moderate (Hurler-Scheie) to severe (Hurler or MPS-IH). A prominent clinical manifestation of MPS-IH is dysostosis multiplex, a constellation of skeletal abnormalities. We performed a retrospective review comparing manifestations of dysostosis multiplex in patients presenting with MPSIH and relevant animal models. Dog, cat and mouse models of MPS-IH are extensively studied to better understand the pathology of the disease. While all animal models display certain characteristics of human MPSIH, species-specific manifestations must be considered when evaluating skeletal abnormalities. Moreover, some skeletal abnormalities emerge at species-specific developmental stages, e.g. thoracolumbar kyphosis is an early manifestation in humans, while it appears late in the mouse model. The choice of the appropriate diagnostic test is of importance to avoid misleading conclusions.
AB - Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder, caused by deficiency of α-L-iduronidase, and consequent accumulation of dermatan and heparan sulfates. Severity of the disease ranges from mild (Scheie) to moderate (Hurler-Scheie) to severe (Hurler or MPS-IH). A prominent clinical manifestation of MPS-IH is dysostosis multiplex, a constellation of skeletal abnormalities. We performed a retrospective review comparing manifestations of dysostosis multiplex in patients presenting with MPSIH and relevant animal models. Dog, cat and mouse models of MPS-IH are extensively studied to better understand the pathology of the disease. While all animal models display certain characteristics of human MPSIH, species-specific manifestations must be considered when evaluating skeletal abnormalities. Moreover, some skeletal abnormalities emerge at species-specific developmental stages, e.g. thoracolumbar kyphosis is an early manifestation in humans, while it appears late in the mouse model. The choice of the appropriate diagnostic test is of importance to avoid misleading conclusions.
KW - Animal models
KW - Bone remodeling biomarkers
KW - Dysostosis multiplex
KW - Mucopolysaccharidosis type I
KW - α-L-iduronidase
UR - http://www.scopus.com/inward/record.url?scp=85089360268&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089360268&partnerID=8YFLogxK
U2 - 10.17458/per.vol17.2020.hpl.dysostosismultiplexhumananimal
DO - 10.17458/per.vol17.2020.hpl.dysostosismultiplexhumananimal
M3 - Article
C2 - 32780955
AN - SCOPUS:85089360268
SN - 1565-4753
VL - 17
SP - 317
EP - 326
JO - Pediatric endocrinology reviews : PER
JF - Pediatric endocrinology reviews : PER
IS - 4
ER -